Somatostatin receptor PET imaging may predict tumor-absorbed doses. The ability to indicate insufficient target irradiation by a low SUV could aid in selection of appropriate candidates for PRRT. However, larger series are needed to confirm and validate these initial findings.
No takes yet. Share an insight, caveat, or question.
Ezziddin et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: